Developer docs
API playgroundTry for free, no card

Search company profiles

Dominion Diagnostics

Full company profile

uuid000fcng

Namestring
Dominion Diagnostics
Legal namestring
Dominion Diagnostics LLC
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Dominion Diagnostics LLC is a U.S. clinical laboratory founded in 1997 and headquartered in North Kingstown, Rhode Island. The company specializes in clinical quantitative urine drug testing and medication monitoring, serving healthcare organizations across five primary verticals: Medication-Assisted Treatment and Opioid Treatment Programs (MAT/OTP), substance use disorder treatment providers, pain management providers, behavioral health programs, and health plans. The core product set spans four laboratory modalities — Urine Drug Testing (UDT), Oral Fluid Testing, Urine STI Testing, and Blood Testing — delivered as a single-source laboratory solution with industry-low detection limits and rapid turnaround times.

The technical foundation is a clinical laboratory testing platform wrapped in a proprietary web-based client portal called DominionConnect, which interfaces with over 100 different EHR systems through Change Healthcare integration. On top of the core testing services, Dominion layers add-on modules including an Automated Randomization Tool for compliance-driven specimen selection, Dynamic Results Reports backed by clinically validated references, Treatment Outcome Reports, and a Customizable Test Menu. Adjacent services include a Telehealth Solutions offering, real-time clinical consultation from an in-house pharmacist team, education and training programs, and a client services operation with dedicated account representatives and a self-serve supplies ordering channel.

Commercially, Dominion operates as a private, founder-owned LLC (founder Frank A. Fornari) with no disclosed institutional investment beyond a single 2010 funding round of $8.3M. Revenue is generated through per-test laboratory services, recurring subscription access to the portal and connectivity layer, and transaction-fee supply sales, with pricing handled via direct sales outreach rather than public disclosure. The go-to-market is a sales-led enterprise motion targeting healthcare organizations and health plans, supported by direct phone sales, white-glove client support, content marketing, and clinical training programs. The company holds no publicly listed patents, awards, or regulatory actions in the source materials and operates exclusively in the United States.

Short descriptiontext

Dominion Diagnostics is a U.S. clinical laboratory founded in 1997 that delivers quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing to substance use disorder treatment, pain management, behavioral health, and health plan customers via its DominionConnect portal and 100+ EHR integrations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNorth Kingstown, United States
HQ citystring
North Kingstown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, urine drug testing, toxicology screening, medication monitoring, substance use disorder testing
Industry3 codes
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Toxicology Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Testing Services
TypeSubscription Recurring
Description

Revenue from comprehensive drug testing services including urine drug testing, oral fluid testing, urine STI testing, and blood testing. Services provided to healthcare organizations on a per-test or subscription basis.

domdiag.com
2Supply Sales
TypeTransaction Fee
Description

Sales of specimen collection supplies, shipping materials, and related equipment needed for in-clinic sample collection and testing protocols.

domdiag.com
3Portal and Connectivity Services
TypeSubscription Recurring
Description

Online portal access for ordering, results reporting, and clinical decision support. Includes EMR/EHR integration services.

domdiag.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Dominion Diagnostics is a clinical laboratory that performs quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing for medication monitoring and substance use disorder treatment programs. Services are supported by the proprietary DominionConnect portal, customizable test menus, and EMR/EHR integration with over 100 EHR systems via Change Healthcare.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Industry-low detection limits for medication monitoring
+2 more records
Product overview1 text field

Dominion Diagnostics is a clinical laboratory offering a platform-plus-services portfolio centered on toxicology testing for substance use disorder, pain management, and behavioral health providers. The core offering spans four laboratory testing products — Urine Drug Testing, Oral Fluid Testing, Urine STI Testing, and Blood Testing — supported by a proprietary DominionConnect Portal that provides connectivity to over 100 EHR systems via Change Healthcare integration. On top of the core platform, the company layers add-on modules including an Automated Randomization Tool, Dynamic Results Reports, Treatment Outcome Reports, and a Customizable Test Menu. Adjacent services include Telehealth Solutions, a Clinical Pharmacist Team for real-time consultation, Education & Training programs, and Client Services & Supplies. The product portfolio is designed as an integrated workflow: providers order via the portal or supplies, submit specimens, receive actionable clinical reports, and can access pharmacist support — all within a single laboratory partner.

Product and service1 record
1Urine Drug Testing (UDT)
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Dominion Diagnostics utilizes Change Healthcare integration capabilities to interface with over 100 different EHR systems. This integration enables seamless connectivity between Dominion's laboratory testing services and healthcare provider electronic medical record systems, facilitating efficient order entry and results reporting workflows.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major academic and reference laboratory offering toxicology and clinical drug monitoring among a broad specialty test menu. Competes with Dominion for hospital and large health system toxicology contracts.

TypeBroad incumbent
Description

Major national clinical laboratory with established toxicology and medication monitoring services. Competes with Dominion for SUD treatment programs, pain practices, and health plan toxicology contracts.

TypeDirect peer
Description

Regional clinical laboratory offering toxicology and medication monitoring for healthcare providers. Competes for pain management and substance use testing orders across overlapping geographies.

TypeDirect peer
Description

Specialty toxicology laboratory providing urine drug testing and medication monitoring services. Overlaps with Dominion in serving SUD treatment providers and pain management practices.

TypeDirect peer
Description

Specialty clinical laboratory focused on clinical drug testing and medication monitoring via urine and oral fluid. Direct competitor for SUD treatment, pain management, and behavioral health toxicology work.

TypeBroad incumbent
Description

One of the two largest U.S. clinical laboratory networks, offering a broad menu including urine drug testing, oral fluid, and toxicology. Serves overlapping provider and payer segments as Dominion and competes on the same UDT, pain management, and SUD testing RFPs.

TypeDirect peer
Description

Nashville-based specialty toxicology laboratory known for medication monitoring and drug testing for SUD and pain management. Closely comparable in vertical, customer base, and test menu to Dominion.

TypeEmerging player
Description

Specialty toxicology and clinical laboratory focused on medication monitoring and UDT services for SUD and pain management. Comparable niche positioning but smaller scale than Dominion.

9Sonora Quest Laboratories
TypeRegional player
Description

Southwest-anchored clinical laboratory network offering toxicology and drug testing. Comparable service line but with concentrated regional coverage versus Dominion's broader national reach.

TypeDirect peer
Description

Historically a leading UDT provider to pain management physicians, now operating under Millennium Health. Closely comparable in target customer (chronic pain prescribers), test menu, and reports positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dominion Diagnostics

Clinical Toxicology Laboratory Servicesdominiondiagnostics.com

Dominion Diagnostics is a U.S. clinical laboratory founded in 1997 that delivers quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing to substance use disorder treatment, pain management, behavioral health, and health plan customers via its DominionConnect portal and 100+ EHR integrations.

What Dominion Diagnostics does

Dominion Diagnostics LLC is a U.S. clinical laboratory founded in 1997 and headquartered in North Kingstown, Rhode Island. The company specializes in clinical quantitative urine drug testing and medication monitoring, serving healthcare organizations across five primary verticals: Medication-Assisted Treatment and Opioid Treatment Programs (MAT/OTP), substance use disorder treatment providers, pain management providers, behavioral health programs, and health plans. The core product set spans four laboratory modalities — Urine Drug Testing (UDT), Oral Fluid Testing, Urine STI Testing, and Blood Testing — delivered as a single-source laboratory solution with industry-low detection limits and rapid turnaround times.

The technical foundation is a clinical laboratory testing platform wrapped in a proprietary web-based client portal called DominionConnect, which interfaces with over 100 different EHR systems through Change Healthcare integration. On top of the core testing services, Dominion layers add-on modules including an Automated Randomization Tool for compliance-driven specimen selection, Dynamic Results Reports backed by clinically validated references, Treatment Outcome Reports, and a Customizable Test Menu. Adjacent services include a Telehealth Solutions offering, real-time clinical consultation from an in-house pharmacist team, education and training programs, and a client services operation with dedicated account representatives and a self-serve supplies ordering channel.

Commercially, Dominion operates as a private, founder-owned LLC (founder Frank A. Fornari) with no disclosed institutional investment beyond a single 2010 funding round of $8.3M. Revenue is generated through per-test laboratory services, recurring subscription access to the portal and connectivity layer, and transaction-fee supply sales, with pricing handled via direct sales outreach rather than public disclosure. The go-to-market is a sales-led enterprise motion targeting healthcare organizations and health plans, supported by direct phone sales, white-glove client support, content marketing, and clinical training programs. The company holds no publicly listed patents, awards, or regulatory actions in the source materials and operates exclusively in the United States.

Dominion Diagnostics firmographics

Firmographics
Name
Dominion Diagnostics
Legal name
Dominion Diagnostics LLC
Website
https://dominiondiagnostics.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
251–500 employees
Short description
Dominion Diagnostics is a U.S. clinical laboratory founded in 1997 that delivers quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing to substance use disorder treatment, pain management, behavioral health, and health plan customers via its DominionConnect portal and 100+ EHR integrations.
Ownership category
akta.pro rank

Dominion Diagnostics industry classification

Industry
Product category
Clinical Toxicology Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Clinical laboratory services
  • Urine drug testing
  • Toxicology screening
  • Medication monitoring
  • Substance use disorder testing

Where Dominion Diagnostics is headquartered

Location

Headquarters

HQ city
North Kingstown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Dominion Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Laboratory Testing Services: Revenue from comprehensive drug testing services including urine drug testing, oral fluid testing, urine STI testing, and blood testing. Services provided to healthcare organizations on a per-test or subscription basis.
  2. Supply Sales: Sales of specimen collection supplies, shipping materials, and related equipment needed for in-clinic sample collection and testing protocols.
  3. Portal and Connectivity Services: Online portal access for ordering, results reporting, and clinical decision support. Includes EMR/EHR integration services.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Dominion Diagnostics product offering

Product offering

Core offering

Dominion Diagnostics is a clinical laboratory that performs quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing for medication monitoring and substance use disorder treatment programs. Services are supported by the proprietary DominionConnect portal, customizable test menus, and EMR/EHR integration with over 100 EHR systems via Change Healthcare.

Product overview

Dominion Diagnostics is a clinical laboratory offering a platform-plus-services portfolio centered on toxicology testing for substance use disorder, pain management, and behavioral health providers. The core offering spans four laboratory testing products — Urine Drug Testing, Oral Fluid Testing, Urine STI Testing, and Blood Testing — supported by a proprietary DominionConnect Portal that provides connectivity to over 100 EHR systems via Change Healthcare integration. On top of the core platform, the company layers add-on modules including an Automated Randomization Tool, Dynamic Results Reports, Treatment Outcome Reports, and a Customizable Test Menu. Adjacent services include Telehealth Solutions, a Clinical Pharmacist Team for real-time consultation, Education & Training programs, and Client Services & Supplies. The product portfolio is designed as an integrated workflow: providers order via the portal or supplies, submit specimens, receive actionable clinical reports, and can access pharmacist support — all within a single laboratory partner.

Differentiator

Problem solved

Functional benefit

Products and services

  • Urine Drug Testing (UDT)

Quantifiable outcome

  • Industry-low detection limits for medication monitoring
  • +2 more outcomes

Companies that use Dominion Diagnostics

Customer profile

Segments5 records

Ideal customer profiles4 records

Dominion Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Dominion Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Change HealthcarecoreTechnology or IntegrationDominion Diagnostics utilizes Change Healthcare integration capabilities to interface with over 100 different EHR systems. This integration enables seamless connectivity between Dominion's laboratory testing services and healthcare provider electronic medical record systems, facilitating efficient order entry and results reporting workflows.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Dominion Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • ARUP Laboratories: Major academic and reference laboratory offering toxicology and clinical drug monitoring among a broad specialty test menu. Competes with Dominion for hospital and large health system toxicology contracts.
  • Laboratory Corporation of America (Labcorp): Major national clinical laboratory with established toxicology and medication monitoring services. Competes with Dominion for SUD treatment programs, pain practices, and health plan toxicology contracts.
  • Quest Diagnostics: One of the two largest U.S. clinical laboratory networks, offering a broad menu including urine drug testing, oral fluid, and toxicology. Serves overlapping provider and payer segments as Dominion and competes on the same UDT, pain management, and SUD testing RFPs.

Direct peers

  • Clinical Pathology Laboratories (CPL): Regional clinical laboratory offering toxicology and medication monitoring for healthcare providers. Competes for pain management and substance use testing orders across overlapping geographies.
  • Precision Diagnostics: Specialty toxicology laboratory providing urine drug testing and medication monitoring services. Overlaps with Dominion in serving SUD treatment providers and pain management practices.
  • Millennium Health: Specialty clinical laboratory focused on clinical drug testing and medication monitoring via urine and oral fluid. Direct competitor for SUD treatment, pain management, and behavioral health toxicology work.
  • Aegis Sciences Corporation: Nashville-based specialty toxicology laboratory known for medication monitoring and drug testing for SUD and pain management. Closely comparable in vertical, customer base, and test menu to Dominion.
  • Ameritox (now part of Millennium Health): Historically a leading UDT provider to pain management physicians, now operating under Millennium Health. Closely comparable in target customer (chronic pain prescribers), test menu, and reports positioning.

Emerging players

  • Alcala Labs (Pathology Inc.): Specialty toxicology and clinical laboratory focused on medication monitoring and UDT services for SUD and pain management. Comparable niche positioning but smaller scale than Dominion.

Regional players

  • Sonora Quest Laboratories: Southwest-anchored clinical laboratory network offering toxicology and drug testing. Comparable service line but with concentrated regional coverage versus Dominion's broader national reach.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Dominion Diagnostics social profiles

Digital presence

Dominion Diagnostics compliance and trust

Trust signal

Compliance1 record

Dominion Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dominion Diagnostics leadership team

Management profile

Number of profiles

Profiles1 record

Dominion Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dominion Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dominion Diagnostics

What does Dominion Diagnostics do?

Dominion Diagnostics is a clinical laboratory that performs quantitative urine drug testing, oral fluid testing, urine STI testing, and blood testing for medication monitoring and substance use disorder treatment programs. Services are supported by the proprietary DominionConnect portal, customizable test menus, and EMR/EHR integration with over 100 EHR systems via Change Healthcare.

Is Dominion Diagnostics a public or private company?

Dominion Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dominion Diagnostics founded?

Dominion Diagnostics was founded in 1997. It employs 251 to 500 people.

Where is Dominion Diagnostics based?

Dominion Diagnostics is headquartered in North Kingstown, United States, in the North America region.

How does Dominion Diagnostics make money?

Three revenue lines are on record. Laboratory Testing Services are the primary driver. The others are supply Sales and portal and Connectivity Services.

Who are Dominion Diagnostics's main competitors?

Broad incumbents on record are ARUP Laboratories, Laboratory Corporation of America (Labcorp) and Quest Diagnostics. Direct peers are Clinical Pathology Laboratories (CPL), Precision Diagnostics, Millennium Health, Aegis Sciences Corporation and Ameritox (now part of Millennium Health). Alcala Labs (Pathology Inc.) is listed as an emerging player. Sonora Quest Laboratories is listed as a regional player.

Does Dominion Diagnostics have an API?

No public API is recorded for Dominion Diagnostics.

What industry is Dominion Diagnostics in?

Dominion Diagnostics's product category is Clinical Toxicology Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Quiver QuantitativeProfusa Enters Option Agreement to Acquire G3 Vision Labs and Subsidiaries | PFSA Stock NewsProfusa, Inc. signed an Option Agreement to acquire G3 Vision Labs, Inc. and its subsidiaries Med Screen Laboratories Inc., Dominion Diagnostics LLC, and Acutis Diagnostics Inc., with G3's estimated 2025 net revenues at approximately $111 million. The option is contingent on Profusa securing at least $30 million in financing, refinancing G3's indebtedness, and obtaining shareholder and Nasdaq approvals. If completed, the combined company would operate as a public diagnostics company with national CLIA-certified laboratories serving addiction treatment, pain management, and behavioral health providers.FinancialContent Business PageProfusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision LabsProfusa, Inc. has signed an Option Agreement granting it the right to acquire G3 Vision Labs, Inc. and its subsidiaries—Med Screen Laboratories Inc., Dominion Diagnostics LLC, and Acutis Diagnostics Inc.—subject to satisfaction of specified conditions including a minimum $30 million financing and refinancing of certain G3 indebtedness. G3's 2025 net revenues are estimated at approximately $111 million, and as consideration for the option, Profusa issued 201,120 shares of common stock and 52,903.566 shares of preferred stock to G3 stockholders. If the option is exercised and conditions are met, the combined entity would operate as a public diagnostics company with national CLIA-certified laboratories serving addiction treatment, pain management, and behavioral health providers.Stock TitanProfusa Signs G3 Acquisition Option, Est. ~$111M 2025 RevenueProfusa, Inc. (Nasdaq: PFSA) has signed an Option Agreement granting it the right to acquire G3 Vision Labs, Inc., a commercial-stage diagnostics company with estimated 2025 net revenues of approximately $111 million. G3 operates through subsidiaries Med Screen Laboratories Inc., Dominion Diagnostics LLC, and Acutis Diagnostics Inc., providing molecular diagnostic and clinical toxicology testing services. The option is exercisable subject to conditions including at least $30 million in financings, refinancing of G3's indebtedness, and stockholder approval.Providence Business NewsBlue Cross, Greater Providence Chamber announce 2026 Worksite Health AwardsBlue Cross & Blue Shield of Rhode Island and the Greater Providence Chamber announced 48 Rhode Island companies as winners of the 32nd annual Worksite Health Awards. Recipients were scored into three tiers based on programs like health screenings and flexible schedules, with Exemplary, Superior, and Outstanding recognition. Brown University, Ocean State Job Lot, and Providence College also received Inspiring Voices awards.Providence Business NewsDominion Diagnostics LLCDominion Diagnostics LLC, a large company in Rhode Island with 213 employees, was named a Best Place to Work in 2022. The company reports an employee assistance program, wellness activities, and a preference for internal promotions.PR NewswireDominion Diagnostics Offering COVID-19 Serology Antibody TestingDominion Diagnostics announced it is now offering COVID-19 serology antibody testing using the Siemens SARS-CoV-2 Total Antibody test. The test detects Immunoglobulin M (IgM) antibodies, which appear early and last 3-4 weeks, and Immunoglobulin G (IgG) antibodies, which may provide longer-term immunity. Performance data showed 100% sensitivity for samples collected 14 or more days after a positive PCR result and 99.8% specificity based on pre-pandemic sample testing.PR NewswireDominion Diagnostics Establishes New Scholarship to Enhance Access to Vermont Recovery ResidencesDominion Diagnostics has established a new scholarship, the Dominion Diagnostics VFOR Scholarship, initially funded at $9,000 and launching in January 2019 to support the Vermont Foundation of Recovery. The scholarship will help provide financial assistance for housing deposits and first month's rent to individuals transitioning from addiction treatment to independent living, addressing a critical gap identified by the Vermont Governor's Opioid Coordination Council. The program incorporates a pay-it-forward concept where recipients who regain stability are encouraged to contribute back to support future individuals in recovery.PR NewswireDominion Diagnostics recognized for expanded testing launch and poised for new clinical research partnershipsDominion Diagnostics launched an expanded discovery testing menu as part of its new Dominion Discovery initiative, offering pharmacokinetic method development and analytical drug development services. The company is actively collaborating with research institutions, such as Roger Williams University, to expand its clinical research partnerships and national reach.PR NewswireDominion Diagnostics Employees Observe International Overdose Awareness DayRhode Island-based medical laboratory Dominion Diagnostics held an internal event for its employees on International Overdose Awareness Day to commemorate lives lost to drug overdose and raise awareness about the crisis. Vice President Mary P. Hauser shared statistics showing approximately 66,000 overdose deaths in 2016 and over 72,000 in 2017, emphasizing the deadliness of drugs circulating on the street. The company's drug testing and medication monitoring services, which span the United States, aim to help treatment providers support patients in recovery and prevent relapse and potential overdose.